03.07.2013
![]()
DGAP-News: Celesio AG: Changes in the Management Board of Celesio AG
DGAP-News: Celesio AG / Key word(s): Change of Personnel
Celesio AG: Changes in the Management Board of Celesio AG
03.07.2013 / 17:23
---------------------------------------------------------------------
Changes in the Management Board of Celesio AG
- Markus Pinger dismissed as Chief Executive Officer
- Dr Marion Helmes spokesperson of the Board with immediate effect
Stuttgart, 3 July 2013 - In a meeting of the Celesio Supervisory Board
today Markus Pinger (50) has been dismissed as Chief Executive Officer and
Member of the Management Board of the Celesio AG with immediate effect. The
separation is due to different opinions of the management of the company.
Dr Marion Helmes (47) will take over provisionally the function as
spokesperson of the Management Board of the Celesio AG in addition to her
function as Chief Financial Officer.
'The Celesio Supervisory Board would like to thank Markus Pinger for his
work in the Management Board', says Stephan Gemkow, Chairman of the
Supervisory Board. 'Dr Helmes has contributed decisively to the chosen path
of the realignment of the group. The Supervisory Board is looking forward
to working together with Mrs. Helmes in her extended responsibilities.'
Press contact
Marc Binder, Celesio AG, +49 (0)711.5001-380
[email protected]
Rainer Berghausen, Celesio AG, +49 (0)711.5001-549
[email protected]
About Celesio Group
As a leading international trading company and provider of logistics and
services in the pharmaceutical and healthcare sector, Celesio takes a
proactive and preventive approach to ensuring that patients receive the
products and support that they require for optimum care. With 39,000
employees, we operate in 16 countries around the world. Every day, we serve
over 2 million customers - at 2,200 pharmacies of our own and 4,100
participants in our brand partnership schemes. With around 140 wholesale
branches, we supply approximately 65,000 pharmacies and hospitals every day
with up to 130,000 pharmaceutical products. Our services benefit a patient
pool of about 15 million per day.
End of Corporate News
---------------------------------------------------------------------
03.07.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Germany
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-740
E-mail: [email protected]
Internet: www.celesio.com
ISIN: DE000CLS1001
WKN: CLS100
Indices: MDAX
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), München, Stuttgart; Freiverkehr in Hamburg,
Hannover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
219753 03.07.2013
|